4880.T
Price:
$644
Market Cap:
$12.76B
CellSource Co., Ltd. engages in the regenerative medicine-related and consumer businesses. It also offers Signalift, an anti-aging product. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.
Industry
Biotechnology
IPO Date
2019-10-29
Stock Exchange
JPX
Ticker
4880.T
According to CellSource Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 53.98. This represents a change of 1.12% compared to the average of 4.43 of the last 4 quarters.
The mean historical PE Ratio of CellSource Co., Ltd. over the last ten years is 104.92. The current 53.98 PE Ratio has changed 5.04% with respect to the historical average. Over the past ten years (40 quarters), 4880.T's PE Ratio was at its highest in in the July 2020 quarter at 264.24. The PE Ratio was at its lowest in in the January 2025 quarter at -92.48.
Average
104.92
Median
89.68
Minimum
36.47
Maximum
186.58
Discovering the peaks and valleys of CellSource Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 170.84%
Maximum Annual PE Ratio = 186.58
Minimum Annual Increase = -56.80%
Minimum Annual PE Ratio = 36.47
Year | PE Ratio | Change |
---|---|---|
2024 | 98.79 | 170.84% |
2023 | 36.47 | -54.74% |
2022 | 80.58 | -56.53% |
2021 | 185.38 | -0.64% |
2020 | 186.58 | 138.29% |
2019 | 78.30 | 49.80% |
2018 | 52.27 | -56.80% |
The current PE Ratio of CellSource Co., Ltd. (4880.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
71.95
5-year avg
117.56
10-year avg
104.92
CellSource Co., Ltd.’s PE Ratio is greater than giftee Inc. (-93.12), less than BASE, Inc. (139.42), greater than StemRIM (-9.21), greater than Makuake, Inc. (42.67), less than GNI Group Ltd. (127.05),
Company | PE Ratio | Market cap |
---|---|---|
-93.12 | $47.79B | |
139.42 | $46.80B | |
-9.21 | $19.01B | |
42.67 | $9.43B | |
127.05 | $125.27B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CellSource Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CellSource Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is CellSource Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for CellSource Co., Ltd. (4880.T)?
What is the highest PE Ratio for CellSource Co., Ltd. (4880.T)?
What is the 3-year average PE Ratio for CellSource Co., Ltd. (4880.T)?
What is the 5-year average PE Ratio for CellSource Co., Ltd. (4880.T)?
How does the current PE Ratio for CellSource Co., Ltd. (4880.T) compare to its historical average?